MetadataShow full item record
AbstractEtoposide was given by three weekly 24-hour infusions (600 mg/m2) to 35 patients with extensive-stage lung cancer. Only two partial responses were achieved; both were of short duration. Pharmacokinetic data suggested that low peak serum concentrations of etoposide were obtained, and it is suggested that if this method of administration is used, higher doses of etoposide be employed.
CitationEtoposide infusions for treatment of metastatic lung cancer. 1984, 68 (6):897-9 Cancer Treat Rep
JournalCancer Treatment Reports
- Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
- Authors: Hainsworth JD, Greco FA
- Issue date: 1995 Dec
- [Effects of oral etoposide in small cell carcinoma of the lung].
- Authors: Miyamoto H, Ito M, Araya Y, Takaoka K, Isobe H, Dosaka H, Kawakami Y, Shimizu T, Onodera S
- Issue date: 1984 Jun
- [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
- Authors: Furuse K
- Issue date: 1985 Dec
- High-dose etoposide with autologous bone marrow transplantation as initial treatment of small cell lung cancer--a negative report.
- Authors: Littlewood TJ, Bentley DP, Smith AP
- Issue date: 1986 May
- Pharmacokinetic evaluation of increasing dosages of etoposide in a chronic hemodialysis patient.
- Authors: Holthuis JJ, Van de Vyver FL, van Oort WJ, Verleun H, Bakaert AB, De Broe ME
- Issue date: 1985 Nov